Danaher Corporation $DHR Stock Holdings Lifted by Eastern Bank

Key Points

• Eastern Bank increased its holdings in Danaher Corporation by 1.6% during Q2, now owning a total of 186,533 shares valued at approximately $36.8 million.
• Danaher reported earnings of $1.80 EPS for the last quarter, exceeding estimates by $0.16, and total revenue of $5.94 billion, a 3.4% year-over-year increase.
• The company announced a quarterly dividend of $0.32 per share, with a payout ratio of 27.23%, to be paid on October 31st.

Eastern Bank lifted its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 1.6% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 186,533 shares of the conglomerate's stock after buying an additional 2,958 shares during the quarter. Eastern Bank's holdings in Danaher were worth $36,848,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of DHR. Nuveen LLC acquired a new stake in shares of Danaher in the first quarter valued at approximately $833,941,000. Invesco Ltd. boosted its position in shares of Danaher by 44.5% during the first quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate's stock worth $965,259,000 after buying an additional 1,450,703 shares during the period. Baird Financial Group Inc. boosted its position in shares of Danaher by 290.6% during the first quarter. Baird Financial Group Inc. now owns 1,441,706 shares of the conglomerate's stock worth $295,550,000 after buying an additional 1,072,617 shares during the period. Generation Investment Management LLP boosted its position in shares of Danaher by 33.2% during the first quarter. Generation Investment Management LLP now owns 3,178,124 shares of the conglomerate's stock worth $651,515,000 after buying an additional 791,662 shares during the period. Finally, Parnassus Investments LLC boosted its position in shares of Danaher by 23.3% during the first quarter. Parnassus Investments LLC now owns 3,828,024 shares of the conglomerate's stock worth $784,745,000 after buying an additional 722,636 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Danaher

In other news, Director Teri List sold 2,778 shares of the business's stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director owned 20,751 shares in the company, valued at $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 11.10% of the stock is currently owned by company insiders.

Danaher Stock Performance

Shares of DHR opened at $202.53 on Friday. The firm's 50 day moving average is $200.66 and its 200-day moving average is $197.25. The stock has a market capitalization of $145.02 billion, a P/E ratio of 43.09, a P/E/G ratio of 2.91 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $279.41.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business's revenue was up 3.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher's payout ratio is currently 27.23%.

Wall Street Analysts Forecast Growth

DHR has been the subject of several analyst reports. Bank of America reduced their price objective on Danaher from $230.00 to $220.00 and set a "buy" rating for the company in a research report on Monday, September 22nd. Wells Fargo & Company dropped their price target on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a research report on Wednesday, July 23rd. Royal Bank Of Canada set a $241.00 price target on shares of Danaher in a research report on Tuesday, September 2nd. Weiss Ratings restated a "hold (c-)" rating on shares of Danaher in a research report on Wednesday. Finally, UBS Group dropped their price target on shares of Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a research report on Wednesday, July 23rd. Seventeen research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, Danaher has a consensus rating of "Moderate Buy" and a consensus target price of $244.60.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.